China Biotech Services Holdings Limited
HKEX:8037.HK
0.46 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 211.985 | 1,851.532 | 623.761 | 655.792 | 59.214 | 70.304 | 105.135 | 86.565 | 34.127 | 140.385 | 85.3 | 101.354 | 45.017 | 84.184 | 160.522 | 272.277 | 270.753 | 243.386 | 197.457 |
| Cost of Revenue
| 177.661 | 750.575 | 265.741 | 316.71 | 36.841 | 42.22 | 74.933 | 56.522 | 24.497 | 87.448 | 49.426 | 55.754 | 41.124 | 43.7 | 71.641 | 111.725 | 98.038 | 97.826 | 70.111 |
| Gross Profit
| 34.324 | 1,100.957 | 358.02 | 339.082 | 22.373 | 28.084 | 30.202 | 30.043 | 9.63 | 52.937 | 35.874 | 45.6 | 3.893 | 40.484 | 88.881 | 160.552 | 172.715 | 145.56 | 127.346 |
| Gross Profit Ratio
| 0.162 | 0.595 | 0.574 | 0.517 | 0.378 | 0.399 | 0.287 | 0.347 | 0.282 | 0.377 | 0.421 | 0.45 | 0.086 | 0.481 | 0.554 | 0.59 | 0.638 | 0.598 | 0.645 |
| Reseach & Development Expenses
| 29.042 | 27.76 | 28.677 | 29.192 | 10.68 | 0 | 0 | 0 | 2.4 | 4.021 | 6.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 138.342 | 241.156 | 157.081 | 132.489 | 94.111 | 78.988 | 54.676 | 55.728 | 37.68 | 48.995 | 30.826 | 24.819 | 23.491 | 33.951 | 29.886 | 32.192 | 26.788 | 26.236 | 20.858 |
| Selling & Marketing Expenses
| 14.61 | 13.726 | 11.724 | 11.848 | 12.379 | 16.966 | 16.807 | 19.996 | 6.266 | 31.582 | 28.618 | 23.804 | 22.903 | 27.715 | 98.17 | 161.715 | 181.714 | 118.355 | 81.219 |
| SG&A
| 128.967 | 254.882 | 168.805 | 144.337 | 106.49 | 95.954 | 71.483 | 75.724 | 43.946 | 80.577 | 59.445 | 48.623 | 46.394 | 61.666 | 128.056 | 193.907 | 208.502 | 144.591 | 102.077 |
| Other Expenses
| 3.989 | -3.361 | 0.738 | -5.037 | -0.057 | 0.172 | 0.354 | 0.699 | 0.292 | 1.705 | 0 | 0.428 | -3.074 | -7.001 | -5.846 | 0.768 | 0.62 | 0.459 | 0.189 |
| Operating Expenses
| 161.998 | 251.521 | 168.805 | 139.3 | 106.433 | 95.401 | 71.379 | 75.062 | 43.946 | 80.577 | 92.686 | 57.955 | 46.394 | 54.665 | 128.056 | 194.675 | 209.122 | 145.05 | 102.266 |
| Operating Income
| -127.674 | 851.707 | 189.44 | 200.601 | -84.06 | -69.561 | -73.285 | -69.848 | -50.262 | -63.43 | -18.009 | -11.784 | -42.501 | -16.288 | -74.205 | -34.123 | -36.407 | 0.51 | 25.08 |
| Operating Income Ratio
| -0.602 | 0.46 | 0.304 | 0.306 | -1.42 | -0.989 | -0.697 | -0.807 | -1.473 | -0.452 | -0.211 | -0.116 | -0.944 | -0.193 | -0.462 | -0.125 | -0.134 | 0.002 | 0.127 |
| Total Other Income Expenses Net
| -14.351 | 11.119 | -9.01 | 3.432 | -20.269 | 0.317 | -2.113 | -28.486 | -9.778 | -16.045 | -25.434 | -5.048 | -4.946 | -1.73 | -41.897 | -1.768 | 0.158 | 2.923 | -0.521 |
| Income Before Tax
| -142.025 | 862.826 | 180.668 | 202.802 | -109.593 | -69.244 | -75.398 | -95.139 | -60.04 | -82.333 | -59.704 | -14.773 | -45.595 | -18.018 | -83.439 | -35.891 | -36.249 | 3.433 | 24.559 |
| Income Before Tax Ratio
| -0.67 | 0.466 | 0.29 | 0.309 | -1.851 | -0.985 | -0.717 | -1.099 | -1.759 | -0.586 | -0.7 | -0.146 | -1.013 | -0.214 | -0.52 | -0.132 | -0.134 | 0.014 | 0.124 |
| Income Tax Expense
| -1.319 | 157.258 | 48.096 | 35.179 | -2.11 | 0.189 | 1.132 | 0.479 | -0.389 | 0.613 | 0.527 | 0.086 | 0.445 | 0.047 | 0.978 | 1.534 | 2.084 | -2.905 | 0.606 |
| Net Income
| -95.447 | 705.568 | 132.572 | 167.623 | -107.483 | -64.25 | -63.022 | -50.151 | -62.269 | -82.929 | -60.231 | -20.698 | -43.555 | -16.465 | -83.561 | -37.425 | -38.333 | 0.528 | 25.165 |
| Net Income Ratio
| -0.45 | 0.381 | 0.213 | 0.256 | -1.815 | -0.914 | -0.599 | -0.579 | -1.825 | -0.591 | -0.706 | -0.204 | -0.968 | -0.196 | -0.521 | -0.137 | -0.142 | 0.002 | 0.127 |
| EPS
| -0.099 | 0.73 | 0.14 | 0.17 | -0.11 | -0.073 | -0.079 | -0.071 | -0.21 | -0.97 | -2.12 | -0.84 | -1.79 | -0.96 | -6.19 | -2.78 | -3.03 | 0.051 | 1.99 |
| EPS Diluted
| -0.099 | 0.73 | 0.14 | 0.17 | -0.11 | -0.073 | -0.079 | -0.071 | -0.21 | -0.97 | -2.12 | -0.84 | -1.79 | -0.96 | -6.19 | -2.78 | -3.03 | 0.051 | 1.96 |
| EBITDA
| -73.456 | 936.902 | 255.323 | 249.636 | -86.31 | -57.526 | -66.17 | -86.26 | -55.574 | -71.873 | -16.434 | -10.19 | -38.888 | -12.095 | -74.811 | -27.168 | -31.585 | 4.494 | 28.241 |
| EBITDA Ratio
| -0.347 | 0.492 | 0.413 | 0.367 | -0.963 | -0.84 | -0.269 | -0.635 | -1.063 | -0.223 | -0.193 | -0.096 | -0.923 | -0.119 | -0.248 | -0.106 | -0.117 | 0.018 | 0.143 |